A randomized controlled trial of contingency management for smoking cessation in substance use treatment patients

  1. Roberto Secades-Villa 1
  2. Gema Aonso-Diego 1
  3. Alba González-Roz 1
  1. 1 Universidad de Oviedo
    info

    Universidad de Oviedo

    Oviedo, España

    ROR https://ror.org/006gksa02

Revista:
International journal of clinical and health psychology

ISSN: 1697-2600

Año de publicación: 2022

Volumen: 22

Número: 3

Páginas: 31-40

Tipo: Artículo

DOI: 10.1016/J.IJCHP.2022.100314 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: International journal of clinical and health psychology

Resumen

Background/Objective Contingency management (CM) is one of the most effective interventions for smokers with substance use disorder (SUD), and no empirical assessment of its long-term efficacy has been conducted so far in a real-world context. The objectives were: (1) examine the additive effectiveness of CM on cognitive-behavioral treatment (CBT) for smoking cessation, and (2) examine the relationship between smoking cessation and substance use abstinence. Method A total of 80 participants (75.8% males; Mage = 45.31; SD = 9.64) were assigned to two smoking cessation treatments: CBT or CBT+CM. A set of generalized estimating equations were conducted to examine the effect of treatment condition on smoking outcomes, as well as the effect of smoking status on substance abstinence. Results Adding CM to CBT for smoking cessation improved tobacco abstinence rates at the end-of-treatment (p = .049). Tobacco abstinence rates declined over time (p = .012), but no significant effects of treatment condition were observed across follow-ups (p = .260). Smoking cessation was not significantly related to substance abstinence (p ≥ .488). Conclusions CM facilitates early abstinence in smokers with SUD, although effects subside after treatment termination. The lack of association between smoking abstinence and substance use suggests no jeopardizing effects as a result of quitting smoking.

Referencias bibliográficas

  • Alonso-Diego, G., Gonzalez-Roz, A., Martínez-Loredo, V., Krotter, A., & Secades-Villa, R. (2021). Episodic future thinking for smoking cessation in individuals with substance use disorder: Treatment feasibility and acceptability. Journal of Substance Abuse Treatment, 123, 108259. https://doi.org/10.1016/j.jsat.2020.108259
  • Apollonio, D., Philipps, R., & Bero, L. (2016). Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database of Systematic Review, 11, CD010274. https://doi.org/10.1002/14651858.CD010274.pub2
  • Baca, C. T., & Yahne, C. E. (2009). Smoking cessation during substance abuse treatment. What you need to know. Journal of Substance Abuse Treatment, 36, 205–219. https://doi.org/10.1016/j.jsat.2008.06.003
  • Beckham, J. C., Adkisson, K. A., Hertzberg, J., Kimbrel, N. A., Budney, A. J., Stephens, R. S., et al. (2018). Mobile contingency management as an adjunctive treatment for co-morbid cannabis use disorder and cigarette smoking. Addictive Behaviors, 79, 86–92. https://doi.org/10.1016/j.addbeh.2017.12.007
  • Berg, K., Piper, M., Smith, S., Fiore, M., & Jorenby, D. (2015). Defining and predicting short-term alcohol use changes during a smoking cessation attempt. Addictive Behaviors, 48, 52–57. https://doi.org/10.1016/J.ADDBEH.2015.04.004
  • Businelle, M. S., Rash, C. J., Burke, R. S., & Parker, J. D. (2009). Using vouchers to increase continuing care participation in veterans. Does magnitude matter? The American Journal on Addictions, 18, 122–129. https://doi.org/10.1080/10550490802545125
  • Chen, D. T.-H. (2020). The psychosocial impact of the COVID-19 pandemic on changes in smoking behavior. Evidence from a nationwide survey in the UK. Tobacco Prevention & Cessation, 6, 1–5. https://doi.org/10.18332/TPC/126976
  • Cooney, J. L., Cooper, S., Grant, C., Sevarino, K., Krishnan-Sarin, S., & Gutierrez, I. A. (2017). A randomized trial of contingency management for smoking cessation during intensive outpatient alcohol treatment. Journal of Substance Abuse Treatment, 72, 89–96. https://doi.org/10.1016/j.jsat.2016.07.002
  • DeFulio, A., Rzeszutek, M. J., Furgeson, J., Ryan, S., & Rezania, S. (2021). A smartphone-smartcard platform for contingency management in an inner-city substance use disorder out-patient program. Journal of Substance Abuse Treatment, 120, 108188. https://doi.org/10.1016/J.JSAT.2020.108188
  • Drope, J., Liber, A. C., Cahn, Z., Stoklosa, M., Kennedy, R., Douglas, C. E., et al. (2018). Who’s still smoking? Disparities in adult cigarette smoking prevalence in the United States. CA: A Cancer Journal for Clinicians, 68, 106-115. https://doi.org/10.3322/CAAC.21444.
  • Fagerstrom, K. (2012). Determinants of tobacco use and renaming the FTND to the Fagerstrom test for cigarette dependence. Nicotine & Tobacco Research, 14, 75–78. https://doi.org/10.1093/NTR/NTR137.
  • Fagerstrom, K., & Kozlowski, L. (1990). Nicotine addiction and its assessment. Ear, Nose, and Throat Journal, 69, 763–765.
  • Fine, D. R., Bearnot, B. I., Rigotti, N. A., & Baggett, T. P. (2019). Smoking status and quit behaviors among health center patients with substance use disorders: A national study. Drug and Alcohol Dependence, 202, 6–12. https://doi.org/10.1016/j.drugalc-dep.2019.05.004
  • Fu, S. S., Kodl, M., Willenbring, M., Nelson, D. B., Nugent, S., Gravely, A. A., et al. (2008). Ethnic differences in alcohol treatment outcomes and the effect of concurrent smoking cessation treatment. Drug and Alcohol Dependence, 92, 61–68. https://doi.org/10.1016/J.DRUGALCDEP.2007.06.014
  • Garke, M., Isacsson, N. H., Sorman, K., Bjureberg, J., Hellner, C., Gratz, K. L., et al. (2021). Emotion dysregulation across levels of substance use. Psychiatry Research, 296, 113662. https://doi.org/10.1016/J.PSYCHRES.2020.113662
  • Gentry, S., Craig, J., Holland, R., & Notley, C. (2017). Smoking cessation for substance misuser: A systematic review of qualitative studies on participant and provider beliefs and perceptions. Drug and Alcohol Dependence, 180, 178–192. https://doi.org/10.1016/j.drugalcdep.2017.07.043
  • Ginley, M. K., Pfund, R. A., Rash, C. J., & Zajac, K. (2021). Long-term efficacy of contingency management treatment based on objective indicators of abstinence from illicit substance use up to 1 year following treatment: A meta-analysis. Journal of Consulting and Clinical Psychology, 89, 58–71. https://doi.org/10.1037/ccp0000552
  • Gonzalez-Roz, A., Ruano, L., Aonso-Diego, G., Weidberg, S., & Secades-Villa, R. (2019a). Smoking cessation interventions in substance use treatment facilities. Clinical implications and recommendations for implementation. Adicciones, 31, 327–329. https://doi.org/10.20882/adicciones.366
  • Gonzalez-Roz, A., Secades-Villa, R., & Alonso-Perez, F. (2019b). Effects of combining contingency management with behavioral activation for smokers with depression. Addiction Research and Theory, 27, 114–121. https://doi.org/10.1080/16066359.2018.1463371.
  • Guydish, J., Kapiteni, K., Le, T., Campbell, B., Pinsker, E., & Delucchi, K. (2020). Tobacco use and tobacco services in California substance use treatment programs. Drug and Alcohol Dependence, 214, 108173. https://doi.org/10.1016/j.drugalcdep.2020.108173.
  • Hammond, A. S., Sweeney, M. M., Chikosi, T. U., & Stitzer, M. L. (2021). Digital delivery of a contingency management intervention for substance use disorder: A feasibility study with DynamiCare Health. Journal of Substance Abuse Treatment, 126, 108425. https://doi.org/10.1016/J.JSAT.2021.108425.
  • Hand, D., Ellis, J., Carr, M., Abatemarco, D., & Ledgerwood, D. (2017). Contingency management interventions for tobacco and other substance use disorders in pregnancy. Psychology of Addictive Behaviors, 31, 907–921. https://doi.org/10.1037/adb0000291.
  • Hayhurst, K., Jones, A., Cairns, D., Jahr, S., Williams, E., Eastwood, B., et al. (2020). Tobacco smoking rates in a national cohort of people with substance use disorder receiving treatment. European Addiction Research, 27, 1–5. https://doi.org/10.1159/000508869.
  • Higgins, S. T., Kurti, A. N., & Davis, D. R. (2019). Voucher-based contingency management is efficacious but underutilized in treating addictions. Perspectives on Behavior Science, 42, 501–524. https://doi.org/10.1007/s40614-019-00216-z.
  • Hser, Y., McCarthy, W., & Anglin, M. (1994). Tobacco use as a distal predictor of mortality among long-term narcotics addicts. Preventive Medicine, 23, 61–69. https://doi.org/10.1006/pmed.1994.1009.
  • Hurt, R. D., Offord, K. P., Croghan, I. T., & Gomez-dahl, L. (1996). Mortality following inpatient addictions treatment. JAMA - Journal of the American Medical Association, 275, 1097–1103.https://doi.org/10.1001/jama.275.14.1097.
  • Johnson, A. L., Kaye, J., Baker, T. B., Fiore, M. C., Cook, J. W., & Piper, M. E. (2020). Psychiatric comorbidities in a comparative effectiveness smoking cessation trial. Relations with cessation success, treatment response, and relapse risk factors. Drug and Alcohol Dependence, 207, 107796. https://doi.org/10.1016/J.DRUGALCDEP.2019.107796.
  • Johnson, A. L., & McLeish, A. C. (2016). The indirect effect of emotion dysregulation in terms of negative affect and smoking-related cognitive processes. Addictive Behaviors, 53, 187–192. https://doi.org/10.1016/J.ADDBEH.2015.10.023.
  • Lien, L., Bolstad, I., & Bramness, J. G. (2021). Smoking among inpatients in treatment for substance use disorders. Prevalence and effect on mental health and quality of life. BMC psychiatry, 21, 244. https://doi.org/10.1186/s12888-021-03252-9.
  • Magee, J., & Winhusen, T. (2016). The coupling of nicotine and stimulant craving during treatment for stimulant dependence. Journal of Consulting and Clinical Psychology, 84, 230–237. https://doi.org/10.1037/ccp0000054.
  • McKelvey, K., Thrul, J., & Ramo, D. (2017). Impact of quitting smoking and smoking cessation treatment on substance use outcomes. An updated and narrative review. Addictive Behaviors, 65, 161–170. https://doi.org/10.1016/j.addbeh.2016.10.012.
  • Morris, A. N., El Haj, M., & Moustafa, A. A. (2020). Episodic future thinking in drug addiction. Cognitive, clinical, and neural aspects of drug addiction, 187–204. https://doi.org/10.1016/B978-0-12-816979-7.00008-X.
  • Notley, C., Gentry, S., Livingstone-Banks, J., Bauld, L., Perera, R., & Hartmann-Boyce, J. (2019). Incentives for smoking cessation. Cochrane Database of Systematic Reviews, 7, CD004307. https://doi.org/10.1002/14651858.CD004307.pub6.
  • Orr, M. F., Smith, C. L., Finlay, M., Martin, S. C., Brooks, O., Oluwoye, O. A., et al. (2018). Pilot investigation. Randomized-controlled analog trial for alcohol and tobacco smoking co-addiction using contingency management. Behavioural Pharmacology, 29, 462-468. https://doi.org/10.1097/FBP.0000000000000379.
  • Pfund, R. A., Cook, J. E., McAfee, N. W., Huskinson, S. L., & Parker, J. D. (2021). Challenges to conducting contingency management treatment for substance use disorders: Practice recommendations for clinicians. Professional Psychology: Research and Practice, 52, 137–145. https://doi.org/10.1037/pro0000356.
  • Piercy, H., Garfield, J. B. B., Lubman, D. I., Lam, T., & Manning, V. (2021). Improved rates of treatment success following alcohol and other drug treatment among clients who quit or reduce their tobacco smoking. Drug and Alcohol Review, 40, 78–82. https://doi.org/10.1111/dar.13150.
  • Prochaska, J. J., Delucchi, K., & Hall, S. M. (2004). A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of Consulting and Clinical Psychology, 72, 1144–1156. https://doi.org/10.1037/0022-006X.72.6.1144.
  • Rohsenow, D. J., Martin, R. A., Tidey, J. W., Colby, S. M., & Monti, P. M. (2017). Treating smokers in substance treatment with contingent vouchers, nicotine replacement and brief advice adapted for sobriety settings. Journal of Substance Abuse Treatment, 72, 72–79. https://doi.org/10.1016/j.jsat.2016.08.012.
  • Rohsenow, D. J., Tidey, J. W., Martin, R. A., Colby, S. M., Sirota, A. D., Swift, R. M., et al. (2015). Contingent vouchers and motivational interviewing for cigarette smokers in residential substance abuse treatment. Journal of Substance Abuse Treatment, 55, 29–38. https://doi.org/10.1016/j.jsat.2015.02.010.
  • Secades-Villa, R., Aonso-Diego, G., García-Perez, A., & Gonzalez-Roz, A. (2020). Effectiveness of contingency management for smoking cessation in substance users. A systematic review and meta-analysis. Journal of Consulting and Clinical Psychology, 88, 951–964. https://doi.org/10.1037/ccp0000611.
  • Secades-Villa, R., García-Rodríguez, O., Lopez-Nuñez, C., Alonso-Perez, F., & Fernandez-Hermida, J. R. (2014). Contingency management for smoking cessation among treatment-seeking patients in a community setting. Drug and Alcohol Dependence, 140, 63–68. https://doi.org/10.1016/j.drugalcdep.2014.03.030.
  • Secades-Villa, R., Gonzalez-Roz, A., Vallejo-Seco, G., Weidberg, S., García-Perez, A., & Alonso-Perez, F. (2019). Additive effectiveness of contingency management on cognitive behavioural treatment for smokers with depression. Six-month abstinence and depression outcomes. Drug and Alcohol Dependence, 204, 107495. https://doi.org/10.1016/j.drugalcdep.2019.06.003.
  • Shoptaw, S., Rotheram-Fuller, E., Yang, X., Frosch, D., Nahom, D., Jarvik, M., et al. (2002). Smoking cessation in methadone maintenance. Addiction (Abingdon, England), 97, 1317–1328. https://doi.org/10.1046/j.1360-0443.2002.00221.x.
  • Sohlberg, T., & Bergmark, K. H. (2020). Lifestyle and long-term smoking cessation. Tobacco Use Insights, 13, 1179173X20963062. https://doi.org/10.1177/1179173X20963062.
  • Wang, T. W., Asman, K., Gentzke, A. S., Cullen, K. A., Holder-Hayes, E., Reyes-Guzman, C., et al. (2018). Tobacco product use among adults — United States, 2017. MMWR. Morbidity and Mortality Weekly Report, 67, 1225–1232. https://doi.org/10.15585/mmwr.mm6744a2.
  • Weinberger, A. H., Platt, J., Esan, H., Galea, S., Erlich, D., & Goodwin, R. D. (2017). Cigarette smoking is associated with increased risk of substance use disorder relapse. A nationally representative, prospective longitudinal investigation. The Journal of Clinical Psychiatry, 78, e152–e160. https://doi.org/10.4088/JCP.15M10062.
  • Zastepa, E., Sun, J. C., Clune, J., & Mathew, N. (2020). Adaptation of contingency management for stimulant use disorder during the COVID-19 pandemic. Journal of Substance Abuse Treatment, 118, 108102. https://doi.org/10.1016/J.JSAT.2020.108102.
Fuente de los datos: Dialnet